KAT is a dubious disease in the field of genetic metabolism, with clinical manifestations of complexity and often involving multiple systemic strain. Early identification and standardized clinical treatment are essential for improving prognosis. The diagnosis of the disease requires a combination of clinical manifestations, imaging inspections, laboratory tests and pathological activation.
The platform can assist in matching national and international teams of authoritative experts to provide accurate diagnosis and treatment programs. In recent years, with the development of therapeutic, immune-regulated therapy and precision medicine, many previously difficult-to-treat genetic metabolic disorders have been significantly improved. Treatment needs to be closely monitored for efficacy and adverse reactions, adapted to the timely schedule of disease changes.
Multidisciplinary collaboration (MDT) is particularly important for the comprehensive management of KATs associated with carcinoma deficiency. The platform serves a team of nationally and internationally authoritative experts in the field of genetic metabolism in China's international medical service system, providing the following services to patients: 2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3.
Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.